Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.00 (0.00%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £35.50m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

Grant of Options

28 Nov 2012 07:00

RNS Number : 1565S
IPPlus PLC
28 November 2012
 



28 November 2012

 

IPPlus plc

(the "Company" or the "Group")

 

Grant of Performance Related Options

 

IPPLUS PLC announces that on 27 November 2012 the Company granted performance related options over a total of 700,000 Ordinary Shares of 1p each in the capital of the Company ("Ordinary Shares") (the "2012-2015 Awards") in accordance with the recommendations of the Company's Remuneration committee.

 

The 2012-2015 Awards relate to a performance period beginning on 1 July 2012 and ending on 30 June 2015 and, assuming certain performance targets are met, will ordinarily vest on 13 September 2015 (or such later date as the Company publishes its annual results for the year ending 30 June 2015).

 

The exercise of options granted under the 2012-2015 Awards are subject to the Group's consolidated profit before tax for the financial year ending 30 June 2015 reaching certain specified figures. The Exercise Price for the options granted under the 2012-2015 Awards is 1p per Ordinary Share.

 

These arrangements have been designed to align management and employee interests with those of the Company's shareholders.

 

As part of the 2012-2015 Awards, options were granted to the following Executive Directors:

 

Director

Position

Number of options over Ordinary Shares granted

 

Exercise Price

Market Price at Date of Grant

William Catchpole

CEO

100,000

1p

16.375p

 

R. Stuart Gordon

CFO

100,000

1p

16.375p

 

Geoffrey Forsyth

CTO

100,000

1p

16.375p

 

 

The 2012-2015 Awards are subject to the achievement of performance conditions as specified by the Remuneration Committee and are subject to claw back provisions in certain circumstances.

 

Following the 2012-2015 Awards, the above Directors are interested in the following Ordinary Shares and options over Ordinary Shares in the Company:

 

Director

Number of Ordinary Shares held

Percentage of voting rights in the Company

 

Total options over Ordinary Shares held

Option exercise price

Expiry date of options

William Catchpole

2,506,124

7.89%

101,508

100,000

1p

1p

28 June 2022

26 November 2022

R. Stuart Gordon

897,039

2.82%

101,508

100,000

1p

1p

28 June 2022

26 November 2022

Geoffrey Forsyth

942,657

2.97%

101,508

100,000

1p

1p

28 June 2022

26 November 2022

 

The Company has 31,771,178 Ordinary Shares in issue and a total of 1,334,424 options over Ordinary Shares including the amounts held by the Directors above.

 

 

For further details, please contact:

 

IPPlus plc

William Catchpole - Chief Executive Officer

R Stuart Gordon - Chief Financial Officer

 

+44 844 544 6800

N+1 Singer (NOMAD & Broker)

Aubrey Powell / Alex Wright

+44 20 7496 3000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBIBDBDSDBGDR
Date   Source Headline
14th Apr 20267:00 amRNS-RHIPAA, HITRUST & SOC 2 Type II certification
18th Mar 20267:00 amRNS-RMajor New Reseller Partnership with Global Telco
10th Mar 20263:07 pmRNSHolding(s) in Company
10th Mar 20263:07 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSInterim Results, Analyst Briefing & Investor Pres
23rd Feb 20267:00 amRNS-RNew Major Strategic Reseller Partnership
17th Feb 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
10th Feb 20265:07 pmRNSHolding(s) in Company
6th Feb 202611:26 amRNSHolding(s) in Company
6th Feb 202611:25 amRNSHolding(s) in Company
5th Feb 202612:48 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSTrading Update
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
1st Dec 20252:49 pmRNSResult of AGM
19th Nov 20257:00 amRNS-RStrategic US Healthcare Sector Integration
17th Nov 20253:19 pmRNS-RCMD Presentation Video
14th Nov 20257:00 amRNS-RCMD Presentation & MelloLondon
11th Nov 20257:00 amRNSCapital Markets Day
6th Nov 20254:20 pmRNSAnnual Financial Report & Notice of AGM
25th Sep 20258:45 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
19th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
30th Jul 20253:18 pmRNSDirector Share Purchases
29th Jul 202510:20 amRNSDirector Share Purchase
29th Jul 20257:01 amRNSTrading & Business Update
29th Jul 20257:00 amRNSNew Product Launch
1st Jul 20257:00 amRNSBoard Changes
20th Jun 202512:00 pmRNSIssue of Equity & TVR
3rd Apr 20259:24 amRNSHolding(s) in Company
12th Mar 20253:20 pmRNSDirector Share Purchases
10th Mar 20257:00 amRNS-RPCI Pal and RingCentral Inc Partnership
6th Mar 20252:00 pmRNSPDMR Issue of Options
4th Mar 20253:49 pmRNSDirector Share Purchase
4th Mar 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
18th Feb 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
27th Jan 20257:00 amRNSTrading Update
11th Dec 20242:42 pmRNSHolding(s) in Company
11th Dec 20242:17 pmRNSResult of AGM
11th Dec 20247:00 amRNSAGM Statement
6th Dec 20244:10 pmRNSExercise of Options & TVR
14th Nov 20244:23 pmRNSAnnual Financial Report & Notice of AGM
22nd Oct 20247:00 amRNSFinal Results, Analyst Briefing & Investor Pres
14th Oct 20247:00 amRNSConfirmation of CFO Appointment
19th Sep 20247:00 amRNSAudit Update & Timing of Results
10th Sep 20244:46 pmRNSHolding(s) in Company
28th Aug 20247:00 amRNSTrading Update, New Partner & Notice of Results
22nd Jul 20249:15 amRNSHolding(s) in Company
1st Jul 20245:23 pmRNSExercise of Options, Director Shareholding & TVR
1st Jul 20247:00 amRNSBoard Changes - Appointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.